About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nestle Sa ADR (OP: NSRGY )

100.73 -0.88 (-0.87%)
Streaming Delayed Price Updated: 3:19 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nestle Sa ADR

< Previous 1 2 3 4 5 Next >
IBTA Stock IPO: When Does Ibotta Go Public? What Is the Ibotta IPO Price Range?
Although the upcoming Ibotta IPO brings excitement to the new-listing space, IBTA stock faces a tricky environment. 
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
Trash Bin Alert: 3 Cocoa Stocks to Dump Before the Bitter End
Cocoa prices are still pushing aggressively higher, and may still have room to run. It's why we’re looking at top cocoa stocks to sell. 
Via InvestorPlace
Branding Behemoths: 3 Consumer Staples Stocks With Super Strong Moats
Investors looking for consumer staples stocks with moats should consider these three super strong investments. 
Via InvestorPlace
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
Goldman Sachs urges investors to diversify geographically due to high concentration in US tech stocks, with Japan, healthcare, and European GRANOLAS highlighted as promising markets. 
Via Benzinga
Nestlé To Develop Products For Users Of 'Miracle' Weight-Loss Drugs Like Ozempic, Wegovy
Via Benzinga
Boiling Water Reduces Microplastics: What Does It Mean For Coca-Cola, PepsiCo's Bottled Water Brands?
Microplastics are small plastic fragments found everywhere and can cause harm to human health. Boiling and filtering tap water can reduce them by 90%. 
Via Benzinga
The Steady Eddies: 3 Dividend Stocks for a Decade of Dependable Growth
If you're looking for a steady list of dividend stocks to depend on for the next decade, these are the clear names. 
Via InvestorPlace
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
A group of stocks, which Goldman Sachs dubbed the "Granolas," accounted for 50% of gains of the Stoxx Europe 600 Index for the past year. 
Via Benzinga
Freshpet Stock: Leading the Pack with Solid Earnings Results
Freshpet, a leader in the refrigerated pet food space, has seen its stock soar recently due to impressive financial results. 
Via MarketBeat
Topics Earnings
Exposures Financial
Move Over Magnificent 7, Say Hello to the GRANOLAS
Dive into the compelling world of GRANOLAS stocks: Europe's elite players shaping the future of pharmaceuticals, tech, and consumer goods. 
Via InvestorPlace
Top 3 Struggling Stocks to Avoid as Cocoa Prices Soar
Investors want to keep in mind these stocks to avoid amid higher cocoa prices. Some analysts don’t expect improvement any time soon. 
Via InvestorPlace
22 Blue-Chip European Dividend Growth Stocks
A discussion of insights on European dividend growth stocks. 
Via Talk Markets
Should The Day After The Super Bowl Be A Holiday? Here's What Benzinga Readers Said And What History Shows
The day following the Super Bowl often witnesses decreased productivity and a significant uptick in employee absences. 
Via Benzinga
Game Day Gainers: 3 Food & Beverage Stocks Primed for a Super Bowl Boost
With the big game coming up, Super Bowl stocks become a thing for sports-loving investors looking to profit. 
Via InvestorPlace
3 Purrfect Stocks to Buy for the Booming Pet Care Industry
Despite the post-pandemic slowdown, stocks within the pet care industry are good long-term investments because the revenue trend is higher. 
Via InvestorPlace
Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough
Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).  
Via Benzinga
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company's (NYSE: LLY) Zepbound and Novo Nordisk's  
Via Benzinga
25% of Warren Buffett's Secret Portfolio Is Invested in These 3 ETFs. Here's Why They're Great Picks for 2024.
Buffett didn't personally pick these ETFs. But all three could make him money in the new year. 
Via The Motley Fool
Topics ETFs
Diversifying Your Portfolio With Plant-Based Options
Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market... 
Via Talk Markets
3 Mutual Funds to Invest in for Pro Management and Low Fees
People wanting to invest for the future without actively managing their own money should consider one of these top mutual funds. 
Via InvestorPlace
Are People Done Buying Chips And Soda? Stock Market Winners And Losers From Rise Of Ozempic, Weight-Loss Drugs
With health and wellness becoming increasingly popular in the United States, it’s no surprise that weight-loss drugs like Ozempic and Wegovy have gone viral on TikTok and other social platf 
Via Benzinga
Nestle Shows Sweet Results In Emerging Markets, Plans To Grow Nutritious Segment
Nestle SA (OTCPK: NSRGY) reported a  
Via Benzinga
Obesity Drug Boom, Split Make This Stock a Heavy Bargain
Ozempic users may be losing their appetites for sweets…but Novo Nordisk is one Danish treat that the market may only get hungrier for. 
Via MarketBeat
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior. 
Via Benzinga
Caffeinate Your Returns: 3 Coffee Stocks to Own for the Long Haul
Coffee stocks make sense if you're building a Coffee Can portfolio, especially with these three caffeinated names. 
Via InvestorPlace
Arm's IPO Could Be Valued At $54B, Google Slashes Jobs in Global Recruiting, Starbucks Founder And Former CEO To Leave: Today's Top Stories
Financial Times 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
'Shrinkflation' Shame!: French Supermarket Carrefour Targets PepsiCo, Unilever and Others By Issuing Price Alerts
Carrefour (OTC: CRERF) (OTC: CRRFY) has taken a proactive stance by issuing price alerts on several products as a strategic move to exert pressure on leading consumer goods suppliers such as Nestle... 
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
Nestlé Pilots Project To Produce Low Carbon Fertilizer From Food Waste Streams
Food and beverage giant Nestlé announced today the launch of a new pilot project aimed at producing low-carbon fertilizer using cocoa shells and addressing a major source of agricultural greenhouse gas... 
Via Talk Markets
Does Nestlé's Biotech Segment Make It a Buy?
With a recent divestiture, it isn't clear if its biotech group is driving growth. 
Via The Motley Fool
Nestle Ups The High-End Gifting Game, Buys Major Stake In Premium Chocolate Maker Of Brazil
Nestle S.A. (OTC: NSRGY) inked a deal with Advent International to buy a  
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.